169 related articles for article (PubMed ID: 27776386)
1. Evaluation of Paraoxonase, Arylesterase and Malondialdehyde Levels in Schizophrenia Patients Taking Typical, Atypical and Combined Antipsychotic Treatment.
Güneş M; Camkurt MA; Bulut M; Demir S; İbiloğlu AO; Kaya MC; Atlı A; Kaplan İ; Sir A
Clin Psychopharmacol Neurosci; 2016 Nov; 14(4):345-350. PubMed ID: 27776386
[TBL] [Abstract][Full Text] [Related]
2. Genotype-phenotype Analysis of Paraoxonase 1 in Schizophrenic Patients Treated with Atypical Antipsychotics.
Pavăl D; Nemeș B; Rusu RL; Dronca E
Clin Psychopharmacol Neurosci; 2018 Feb; 16(1):32-38. PubMed ID: 29397664
[TBL] [Abstract][Full Text] [Related]
3. Levels of paraoxonase and arylesterase activities and malondialdehyde in workers exposed to ionizing radiation.
Serhatlioglu S; Gursu MF; Gulcu F; Canatan H; Godekmerdan A
Cell Biochem Funct; 2003 Dec; 21(4):371-5. PubMed ID: 14624476
[TBL] [Abstract][Full Text] [Related]
4. Antioxidant enzymes and lipid peroxidation in different forms of schizophrenia treated with typical and atypical antipsychotics.
Zhang XY; Tan YL; Cao LY; Wu GY; Xu Q; Shen Y; Zhou DF
Schizophr Res; 2006 Jan; 81(2-3):291-300. PubMed ID: 16309894
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of antioxidant enzymes activities and lipid peroxidation in schizophrenic patients treated with typical and atypical antipsychotics.
Padurariu M; Ciobica A; Dobrin I; Stefanescu C
Neurosci Lett; 2010 Aug; 479(3):317-20. PubMed ID: 20561936
[TBL] [Abstract][Full Text] [Related]
6. Serum paraoxonase-1 enzyme activities and oxidative stress levels in patients with esophageal squamous cell carcinoma.
Sehitogulları A; Aslan M; Sayır F; Kahraman A; Demir H
Redox Rep; 2014 Sep; 19(5):199-205. PubMed ID: 24731121
[TBL] [Abstract][Full Text] [Related]
7. Lipid peroxidation markers in adult attention deficit hyperactivity disorder: new findings for oxidative stress.
Bulut M; Selek S; Bez Y; Cemal Kaya M; Gunes M; Karababa F; Celik H; Savas HA
Psychiatry Res; 2013 Oct; 209(3):638-42. PubMed ID: 23680468
[TBL] [Abstract][Full Text] [Related]
8. Coronary artery disease risk factors in patients with schizophrenia: effects of short term antipsychotic treatment.
Sarandol A; Kirli S; Akkaya C; Ocak N; Eroz E; Sarandol E
J Psychopharmacol; 2007 Nov; 21(8):857-63. PubMed ID: 17715203
[TBL] [Abstract][Full Text] [Related]
9. Measurement of serum paraoxonase activity and MDA concentrations in patients suffering with oral squamous cell carcinoma.
Malik UU; Siddiqui IA; Hashim Z; Zarina S
Clin Chim Acta; 2014 Mar; 430():38-42. PubMed ID: 24389054
[TBL] [Abstract][Full Text] [Related]
10. Synergism between apolipoprotein E Ɛ4 allele and paraoxonase (PON1) 55-M allele is associated with risk of systemic lupus erythematosus.
Tanhapour M; Miri A; Vaisi-Raygani A; Bahrehmand F; Kiani A; Rahimi Z; Pourmotabbed T; Shakiba E
Clin Rheumatol; 2018 Apr; 37(4):971-977. PubMed ID: 29273831
[TBL] [Abstract][Full Text] [Related]
11. Paraoxonase 1 (PON1) 55 polymorphism, lipid profiles and psoriasis.
Asefi M; Vaisi-Raygani A; Bahrehmand F; Kiani A; Rahimi Z; Nomani H; Ebrahimi A; Tavilani H; Pourmotabbed T
Br J Dermatol; 2012 Dec; 167(6):1279-86. PubMed ID: 22835076
[TBL] [Abstract][Full Text] [Related]
12. Oxidative damage and schizophrenia: the potential benefit by atypical antipsychotics.
Dakhale G; Khanzode S; Khanzode S; Saoji A; Khobragade L; Turankar A
Neuropsychobiology; 2004; 49(4):205-9. PubMed ID: 15154399
[TBL] [Abstract][Full Text] [Related]
13. Blood-based oxidation markers in medicated and unmedicated schizophrenia patients: A meta-analysis.
Goh XX; Tang PY; Tee SF
Asian J Psychiatr; 2022 Jan; 67():102932. PubMed ID: 34839098
[TBL] [Abstract][Full Text] [Related]
14. Altered lipid peroxidation markers are related to post-traumatic stress disorder (PTSD) and not trauma itself in earthquake survivors.
Atli A; Bulut M; Bez Y; Kaplan İ; Özdemir PG; Uysal C; Selçuk H; Sir A
Eur Arch Psychiatry Clin Neurosci; 2016 Jun; 266(4):329-36. PubMed ID: 26324882
[TBL] [Abstract][Full Text] [Related]
15. Effect of pomegranate juice on paraoxonase enzyme activity in patients with type 2 diabetes.
Parsaeyan N; Mozaffari-Khosravi H; Mozayan MR
J Diabetes Metab Disord; 2012 Aug; 11(1):11. PubMed ID: 23497651
[TBL] [Abstract][Full Text] [Related]
16. Serum paraoxonase activity and oxidative stress levels in patients with cutaneous anthrax.
Karadas S; Aslan M; Ceylan MR; Sunnetcioglu M; Bozan N; Kara H; Demir H
Hum Exp Toxicol; 2017 Jul; 36(7):663-669. PubMed ID: 27461010
[TBL] [Abstract][Full Text] [Related]
17. Paraoxonase 1 activity and lipid profile in schizophrenic patients.
Mabrouk H; Mechria H; Mechri A; Azizi I; Neffati F; Douki W; Gaha L; Najjar MF
Asian J Psychiatr; 2014 Jun; 9():36-40. PubMed ID: 24813034
[TBL] [Abstract][Full Text] [Related]
18. Oxidative status and serum PON1 activity in beta-thalassemia minor.
Selek S; Aslan M; Horoz M; Gur M; Erel O
Clin Biochem; 2007 Mar; 40(5-6):287-91. PubMed ID: 17296173
[TBL] [Abstract][Full Text] [Related]
19. Decreased serum paraoxonase and arylesterase activities in patients with rosacea.
Takci Z; Bilgili SG; Karadag AS; Kucukoglu ME; Selek S; Aslan M
J Eur Acad Dermatol Venereol; 2015 Feb; 29(2):367-370. PubMed ID: 24854673
[TBL] [Abstract][Full Text] [Related]
20. Serum paraoxonase 1 activity and lipid peroxidation levels in patients with age-related macular degeneration.
Baskol G; Karakucuk S; Oner AO; Baskol M; Kocer D; Mirza E; Saraymen R; Ustdal M
Ophthalmologica; 2006; 220(1):12-6. PubMed ID: 16374043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
